Kewaunee Scientific Corporation  

(Public, NASDAQ:KEQU)   Watch this stock  
Find more results for KEQU
+0.20 (0.77%)
Feb 21 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 26.25 - 26.62
52 week 20.95 - 31.20
Open 26.62
Vol / Avg. 763.00/1,800.00
Mkt cap 71.96M
P/E 15.83
Div/yield 0.17/2.57
EPS 1.67
Shares 2.72M
Beta 0.07
Inst. own 48%
Feb 26, 2018
Q3 2018 Kewaunee Scientific Corp Earnings Release (Estimated) Add to calendar
Dec 5, 2017
Q2 2018 Kewaunee Scientific Corp Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Oct '17) 2017
Net profit margin 4.26% 3.33%
Operating margin 6.40% 4.72%
EBITD margin - 6.67%
Return on average assets 8.72% 6.03%
Return on average equity 15.59% 11.13%
Employees 619 -
CDP Score - -


2700 W Front St
United States - Map
+1-704-8737202 (Phone)
+1-302-6745266 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Kewaunee Scientific Corporation is engaged in the design, manufacture and installation of laboratory, healthcare and technical furniture products. The Company's products include steel, wood and laminate furniture, fume hoods, biological safety cabinets, laminar flow and ductless hoods, adaptable modular and column systems, moveable workstations and carts, epoxy resin worksurfaces, sinks, and accessories and related design services. It operates through two segments: Domestic and International. The Domestic business segment designs, manufactures, and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, worksurfaces, workstations, workbenches, and computer enclosures. The International business segment provides facility design, engineering, construction and project management from the planning stage through testing and commissioning of laboratories.

Officers and directors

David M. Rausch President, Chief Executive Officer, Director
Age: 58
Bio & Compensation  - Reuters
Thomas David Hull III Chief Financial Officer, Vice President - Finance, Treasurer, Secretary
Age: 41
Bio & Compensation  - Reuters
Dana L. Dahlgren Vice President - Sales and Marketing of Americas
Age: 61
Bio & Compensation  - Reuters
Elizabeth D. Phillips Vice President - Human Resources
Age: 40
Bio & Compensation  - Reuters
Kurt P. Rindoks Vice President, Product Development and International Sourcing
Age: 59
Bio & Compensation  - Reuters
Michael G. Rok Vice President of Manufacturing Operations
Age: 51
Bio & Compensation  - Reuters
Boopathy Sathyamurthy Vice President, Kewaunee Scientific Corporation Singapore Pte. Ltd. Managing Director, Internatational Operations
Age: 48
Bio & Compensation  - Reuters
William A. Shumaker Non-Executive Chairman of the Board
Age: 69
Bio & Compensation  - Reuters
Keith M. Gehl CPA Independent Director
Age: 58
Bio & Compensation  - Reuters
Margaret B. Pyle Independent Director
Age: 65
Bio & Compensation  - Reuters